Skip Navigation LinksHome > April 2012 - Volume 22 - Issue 2 > Preclinical evaluation of the antineoplastic efficacy of 7-(...
Melanoma Research:
doi: 10.1097/CMR.0b013e328350d228
ORIGINAL ARTICLES: Basic research

Preclinical evaluation of the antineoplastic efficacy of 7-(2-hydroxyethyl)theophylline on melanoma cancer cells

Lentini, Alessandroa; Tabolacci, Claudioa; Nardi, Alessandrab; Mattioli, Palmaa; Provenzano, Brunoa; Beninati, Simonea

Collapse Box

Abstract

Differentiation-based therapeutics are an underutilized but potentially a significant option for cancer treatment. The effect of methylxanthines on melanoma cell differentiation has been well documented. We report the in-vitro and in-vivo anticancer potential of a theophylline analogue, 7-(2-hydroxyethyl)theophylline (HET), on murine B16-F10 and human Sk-Mel 110 metastatic melanoma cell lines. The effects on cell proliferation were related to the induction of differentiation, demonstrated as increased intracellular transglutaminase activity. The involvement of this methylxanthine in the control of the in-vitro adhesion and in the in-vivo metastastic spread of melanoma cells was further investigated. HET oral administration of C57BL6/N mice intravenously injected with B16-F10 cells markedly reduced lung metastases frequency. The overall results demonstrated that HET possesses a remarkable in-vivo antimetastatic capability.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.